It also eliminates the insulin effect on the Akt/glycogen synthase kinase-3β/Cyclin D1 pathway, thereby inhibiting insulin-induced cell proliferation [33], and other ways to inhibit the occurrence and development of nasopharyngeal carcinoma. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.